See analyst estimates and all valuation multiples for Biopharmaceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $966B | 15.2x | 33.5x | |
| $612B | 6.5x | 17.1x | |
| $472B | 7.7x | 18.1x | |
| $398B | 4.9x | 12.5x | |
| $345B | 5.8x | 16.7x | |
| $335B | 5.9x | 14.2x | |
| $327B | 5.0x | 11.0x | |
| $247B | 6.8x | 14.0x | |
| $237B | 4.8x | 10.0x | |
| $210B | 7.2x | 13.1x | |
| $197B | 3.2x | 8.0x | |
| $160B | 3.3x | 8.6x | |
| $138B | 3.1x | 9.2x | |
| $127B | 2.4x | 7.9x | |
| $120B | 10.0x | 22.2x | |
| $91.5B | 11.5x | 22.6x | |
| $89.9B | 1.7x | 7.9x | |
| $83.0B | 2.9x | 10.6x | |
| $77.1B | 3.1x | 10.6x | |
| $62.1B | 3.6x | 10.8x | |
| $60.4B | 6.4x | 14.7x | |
| $53.5B | 5.4x | 18.5x | |
| $53.0B | 3.0x | 10.1x | |
| $50.2B | 10.8x | 36.1x | |
| $50.1B | 10.5x | 34.8x | |
| $42.2B | 6.8x | 23.9x | |
| $41.2B | 3.6x | 16.7x | |
| $38.0B | 13.4x | 37.4x | |
| $33.6B | 2.2x | 8.9x | |
| $32.4B | 2.5x | 12.2x | |
| $31.7B | 2.2x | 7.7x | |
| $31.7B | 2.5x | 10.4x | |
| $31.6B | 3.2x | 10.4x | |
| $26.8B | 9.0x | 9.2x | |
| $24.0B | 11.4x | 29.7x | |
| $21.9B | 2.1x | 6.0x | |
| $19.1B | 9.9x | 109.7x | |
| $18.0B | 2.0x | 8.3x | |
| $17.0B | 5.3x | 13.8x | |
| $16.8B | 52.5x | n/a | |
| $15.6B | 5.0x | 12.5x | |
| $15.4B | 4.1x | 10.9x | |
| $15.4B | 11.1x | 33.6x | |
| $14.8B | 96.3x | 179.4x | |
| $14.5B | 3.2x | 8.5x | |
| $14.1B | 2.9x | 11.0x | |
| $14.1B | 4.5x | 12.0x | |
| $14.0B | 3.5x | 14.1x | |
| $12.9B | 2.2x | 13.5x | |
| $12.9B | 3.8x | 9.0x | |
| $12.7B | 2.1x | 14.3x | |
| $12.6B | n/a | n/a | |
| $12.5B | 26.5x | -1246.4x | |
| $11.8B | 42.3x | -255.8x | |
| $11.8B | 0.3x | 5.0x | |
| $11.8B | 4.1x | 17.8x | |
| $11.5B | 5.1x | 13.8x | |
| $11.5B | 3.1x | 12.5x | |
| $11.0B | 4.0x | 15.5x | |
| $10.7B | 3.4x | 14.0x | |
| $10.3B | 3.7x | 13.4x | |
| $10.2B | 7.6x | 11.6x | |
| $10.1B | 1.6x | 5.2x | |
| $10.0B | 11.7x | 38.3x | |
| $9.9B | 6.4x | 25.7x | |
| $9.3B | 905.1x | -38.4x | |
| $8.8B | 1.4x | 11.0x | |
| $8.6B | 1.7x | 13.6x | |
| $8.5B | 28552.0x | -28.7x | |
| $7.8B | 4.2x | 20.3x | |
| $7.8B | 3.3x | 9.8x | |
| $7.6B | 2.5x | 10.9x | |
| $7.5B | 18.4x | -3072.9x | |
| $7.4B | n/a | n/a | |
| $7.3B | 93.5x | 16374.8x | |
| $7.2B | 2.3x | 9.5x | |
| $7.2B | 2.0x | 9.6x | |
| $7.1B | 2.4x | 10.5x | |
| $7.0B | 14.5x | 43.7x | |
| $6.8B | 4.4x | 21.8x | |
| $6.6B | 2.5x | 3.6x | |
| $6.5B | 1.5x | 8.6x | |
| $6.4B | 2.2x | 5.9x | |
| $6.2B | n/a | n/a | |
| $6.2B | 6.9x | 24.0x | |
| $6.1B | n/a | n/a | |
| $6.1B | 1.8x | 7.1x | |
| $6.1B | n/a | n/a | |
| $6.0B | 3.4x | 22.8x | |
| $6.0B | 8.0x | 29.1x | |
| $5.9B | n/a | n/a | |
| $5.9B | 16.2x | 24.1x | |
| $5.7B | 3.8x | 42.6x | |
| $5.5B | 5.3x | 24.5x | |
| $5.4B | 6.4x | 32.6x | |
| $5.4B | n/a | -20.0x | |
| $5.3B | 2.0x | 11.3x | |
| $5.2B | 8.5x | 25.5x | |
| $4.8B | n/a | -29.1x | |
| $4.8B | 2.4x | 9.1x | |
| $4.8B | 5.5x | 20.5x | |
| $4.6B | 10.9x | 33.2x | |
| $4.5B | 12.5x | -67.9x | |
| $4.5B | n/a | -11.3x | |
| $4.4B | 3.0x | 11.7x | |
| $4.4B | 4.7x | 13.0x | |
| $4.4B | n/a | n/a | |
| $4.2B | 2.9x | 10.6x | |
| $4.2B | 7.9x | 20.7x | |
| $4.1B | n/a | n/a | |
| $4.0B | n/a | -35.7x | |
| $3.9B | 7.5x | 16.4x | |
| $3.8B | 2.2x | 10.9x | |
| $3.8B | n/a | n/a | |
| $3.6B | 5.3x | 15.3x | |
| $3.5B | 5.2x | 13.9x | |
| $3.5B | n/a | -24.2x | |
| $3.5B | 29.3x | -537.4x | |
| $3.4B | 2.4x | 8.9x | |
| $3.4B | 2.6x | 12.1x | |
| $3.3B | 120.7x | -15.7x | |
| $3.3B | 16.3x | 28.0x | |
| $3.1B | 4.6x | 28.9x | |
| $3.1B | 8.6x | -1609.5x | |
| $3.0B | 119.6x | -12.2x | |
| $2.9B | n/a | n/a | |
| $2.9B | 4.1x | 11.9x | |
| $2.7B | n/a | -12.7x | |
| $2.7B | 4.6x | 20.4x | |
| $2.7B | 3.8x | 21.0x | |
| $2.7B | n/a | n/a | |
| $2.6B | 4.3x | 10.5x | |
| $2.6B | 1.3x | 8.4x | |
| $2.6B | 5.2x | 290.1x | |
| $2.5B | 8.7x | 107.7x | |
| $2.4B | 4.0x | 13.0x | |
| $2.4B | 6.0x | 17.8x | |
| $2.4B | 15.3x | 38.1x | |
| $2.4B | 5.3x | -37.2x | |
| $2.3B | 2.7x | 13.8x | |
| $2.3B | n/a | n/a | |
| $2.3B | n/a | n/a | |
| $2.3B | 30.6x | -17.1x | |
| $2.3B | n/a | n/a | |
| $2.3B | 3.5x | 14.0x | |
| $2.2B | 5.6x | 16.3x | |
| $2.2B | 51.8x | -10.8x | |
| $2.1B | 6.8x | 17.9x | |
| $2.1B | 2.4x | 9.2x | |
| $2.0B | 7.5x | 28.9x | |
| $2.0B | 2.5x | 4.3x | |
| $2.0B | 2.8x | 13.3x | |
| $2.0B | 18.2x | 352.1x | |
| $1.9B | n/a | n/a | |
| $1.9B | 12.0x | 26.5x | |
| $1.8B | n/a | n/a | |
| $1.8B | n/a | -12.9x | |
| $1.7B | n/a | n/a | |
| $1.7B | 5.8x | 11.5x | |
| $1.7B | 2.3x | 6.4x | |
| $1.7B | 3.9x | 13.6x | |
| $1.7B | 6.7x | 286.3x | |
| $1.7B | 1628.8x | -16.4x | |
| $1.6B | 724.3x | n/a | |
| $1.6B | 6.6x | -4.5x | |
| $1.6B | 8.8x | 25.8x | |
| $1.6B | 5.7x | 10.8x | |
| $1.6B | 4.0x | -379.4x | |
| $1.6B | n/a | -9.3x | |
| $1.6B | 24.7x | -14.5x | |
| $1.5B | n/a | n/a | |
| $1.5B | 8.1x | 138.3x | |
| $1.5B | n/a | -6.4x | |
| $1.5B | n/a | n/a | |
| $1.5B | n/a | n/a | |
| $1.5B | 12.3x | -28.8x | |
| $1.5B | 0.7x | 3.9x | |
| $1.5B | n/a | -8.8x | |
| $1.5B | 26.9x | n/a | |
| $1.5B | n/a | n/a | |
| $1.4B | 6.0x | 33.5x | |
| $1.4B | n/a | n/a | |
| $1.4B | n/a | -16.1x | |
| $1.4B | 3.6x | 6.1x | |
| $1.4B | n/a | -14.0x | |
| $1.3B | 36.1x | n/a | |
| $1.3B | n/a | -7.0x | |
| $1.3B | 7.8x | -5.0x | |
| $1.3B | 2.2x | -55.6x | |
| $1.3B | 9.1x | 22.5x | |
| $1.3B | 1.2x | 5.2x | |
| $1.3B | 4.5x | 24.6x | |
| $1.2B | 4.1x | 8.2x | |
| $1.2B | n/a | -9.4x | |
| $1.2B | 2.5x | 14.1x | |
| $1.2B | 123.8x | -9.9x | |
| $1.1B | 39.3x | -5.6x | |
| $1.1B | 9.4x | 35.3x | |
| $1.1B | 0.5x | 4.2x | |
| $1.1B | 2.9x | 35.0x | |
| $1.1B | 1.7x | 8.6x | |
| $1.1B | 128828.1x | -9.4x | |
| $1.1B | 6.2x | -7.7x | |
| $1.1B | 2.7x | 11.8x | |
| $1.0B | n/a | n/a | |
| $1.0B | 755.4x | -188.9x | |
| $1.0B | 2.6x | 39.3x | |
| $1.0B | 80.2x | -3.2x | |
| $986M | 1.2x | 4.9x | |
| $982M | 2.1x | 10.3x | |
| $966M | 8.5x | -8.2x | |
| $955M | n/a | -4.7x | |
| $948M | 7.8x | 25.1x | |
| $936M | 20.2x | 128.1x | |
| $930M | 2.2x | 2.6x | |
| $928M | 1114.3x | -82.6x | |
| $924M | 1.5x | -6.8x | |
| $919M | 70.7x | -11.8x | |
| $882M | 54.0x | -16.6x | |
| $874M | n/a | n/a | |
| $870M | 3.0x | 12.8x | |
| $860M | n/a | n/a | |
| $830M | n/a | -7.1x | |
| $817M | 20.9x | -13.1x | |
| $786M | n/a | n/a | |
| $771M | 5.2x | -6.3x | |
| $741M | n/a | n/a | |
| $737M | n/a | n/a | |
| $728M | 53.4x | n/a | |
| $699M | n/a | -4.8x | |
| $689M | n/a | n/a | |
| $660M | n/a | -4.3x | |
| $658M | n/a | n/a | |
| $626M | n/a | n/a | |
| $619M | n/a | n/a | |
| $617M | 3.6x | 22.2x | |
| $567M | n/a | -2.5x | |
| $560M | n/a | n/a | |
| $551M | n/a | n/a | |
| $551M | 20398.2x | n/a | |
| $541M | 76.7x | -6.0x | |
| $538M | 14.6x | 56.2x | |
| $519M | n/a | n/a | |
| $507M | n/a | n/a | |
| $492M | 10.4x | -8.0x | |
| $483M | n/a | -3.2x | |
| $480M | 7.4x | -21.2x | |
| $473M | 20.2x | -8.9x | |
| $460M | 101.0x | -14.8x | |
| $454M | 2.4x | 10.0x | |
| $454M | 1.4x | 9.9x | |
| $452M | n/a | n/a | |
| $446M | 1.3x | 4.8x | |
| $424M | n/a | n/a | |
| $422M | 3.3x | -2.6x | |
| $408M | 30.2x | n/a | |
| $395M | 2.0x | 8.5x | |
| $389M | 63.5x | -1.7x | |
| $384M | 6.0x | 23.3x | |
| $384M | 3.0x | 34.4x | |
| $379M | 1.3x | 10.8x | |
| $379M | 75.8x | -5.5x | |
| $372M | 59588.4x | -4.1x | |
| $360M | 5.4x | 126.3x | |
| $331M | n/a | n/a | |
| $330M | n/a | n/a | |
| $329M | n/a | n/a | |
| $327M | n/a | n/a | |
| $326M | 3.5x | -14.7x | |
| $323M | 0.8x | 9.3x | |
| $318M | n/a | n/a | |
| $315M | 3.2x | 10.8x | |
| $311M | 34.7x | -6.7x | |
| $305M | 3.7x | 144.0x | |
| $302M | n/a | -4.9x | |
| $287M | n/a | n/a | |
| $280M | n/a | n/a | |
| $262M | 5.6x | 45.2x | |
| $256M | n/a | n/a | |
| $254M | 3.6x | 7.8x | |
| $251M | 28.7x | -25.3x | |
| $250M | 5.4x | 26.5x | |
| $244M | 1.7x | 15.5x | |
| $242M | 1045.0x | -5.2x | |
| $241M | n/a | n/a | |
| $240M | n/a | n/a | |
| $238M | n/a | -34.0x | |
| $232M | 4.2x | n/a | |
| $218M | 3.5x | n/a | |
| $214M | 29.0x | -6.5x | |
| $211M | n/a | n/a | |
| $208M | 10.8x | -4.9x | |
| $207M | 10.9x | -2.6x | |
| $206M | 1.0x | -1.9x | |
| $205M | 0.9x | n/a | |
| $199M | n/a | n/a | |
| $194M | 5.8x | -1.0x | |
| $176M | 2.7x | n/a | |
| $174M | 13.4x | -6.2x | |
| $169M | n/a | n/a | |
| $168M | 5.4x | -2.3x | |
| $161M | 14.9x | n/a | |
| $153M | 4.8x | 7.3x | |
| $151M | 27.9x | -12.8x | |
| $143M | n/a | n/a | |
| $142M | 39.0x | -2.6x | |
| $139M | 6.3x | 62.3x | |
| $138M | n/a | -2.3x | |
| $137M | n/a | n/a | |
| $125M | n/a | -34.1x | |
| $125M | n/a | n/a | |
| $124M | n/a | -0.9x | |
| $122M | 7.1x | -2.1x | |
| $121M | 28.7x | -8.2x | |
| $120M | 79.7x | -21.3x | |
| $118M | 68.0x | -9.8x | |
| $117M | n/a | n/a | |
| $116M | 2.9x | -14.9x | |
| $115M | 4.3x | -3.1x | |
| $111M | 1.5x | 9.3x | |
| $110M | n/a | n/a | |
| $107M | n/a | n/a | |
| $107M | n/a | n/a | |
| $105M | n/a | n/a | |
| $104M | 8.6x | 153.2x | |
| $103M | n/a | -7.7x | |
| $102M | 38.2x | -0.7x | |
| $100M | 1.3x | -0.4x | |
| $96.9M | 9.6x | 20.7x | |
| $87.7M | n/a | n/a | |
| $83.9M | 9.0x | -3.6x | |
| $79.1M | n/a | n/a | |
| $77.5M | 0.9x | 5.5x | |
| $69.3M | n/a | n/a | |
| $69.0M | n/a | n/a | |
| $68.8M | 3.9x | -1.6x | |
| $66.8M | n/a | -10.5x | |
| $65.3M | n/a | n/a | |
| $61.8M | n/a | n/a | |
| $61.8M | n/a | n/a | |
| $60.8M | 57.8x | -2.0x | |
| $59.7M | n/a | n/a | |
| $58.7M | 64.1x | -5.4x | |
| $58.2M | 1.0x | 259.8x | |
| $57.9M | n/a | n/a | |
| $55.9M | 0.6x | -0.9x | |
| $55.1M | n/a | n/a | |
| $53.5M | 119.3x | -8.1x | |
| $51.0M | n/a | n/a | |
| $50.5M | n/a | n/a | |
| $50.5M | n/a | n/a | |
| $50.0M | 4.8x | 2.1x | |
| $46.6M | 0.2x | -1.0x | |
| $43.6M | n/a | -3.4x | |
| $43.5M | 29.4x | -53.2x | |
| $43.2M | n/a | n/a | |
| $40.4M | 10.8x | -9.7x | |
| $39.5M | n/a | n/a | |
| $39.0M | n/a | -8.9x | |
| $38.6M | 9.5x | -1.2x | |
| $37.0M | n/a | n/a | |
| $36.3M | n/a | -5.4x | |
| $34.4M | n/a | n/a | |
| $32.0M | 14.0x | -0.4x | |
| $31.3M | 552.2x | -5.2x | |
| $30.8M | 3.8x | -1.5x | |
| $29.4M | 43.7x | -2.8x | |
| $29.3M | 10.5x | -5.3x | |
| $29.1M | n/a | n/a | |
| $26.2M | 6.8x | n/a | |
| $25.7M | n/a | n/a | |
| $25.2M | n/a | n/a | |
| $24.4M | 10.8x | 2.4x | |
| $24.2M | 3.2x | n/a | |
| $22.2M | 15.9x | -7.7x | |
| $22.0M | n/a | n/a | |
| $22.0M | n/a | n/a | |
| $21.8M | n/a | n/a | |
| $21.7M | n/a | -11.8x | |
| $21.6M | 103.3x | -4.6x | |
| $21.0M | n/a | n/a | |
| $20.8M | n/a | n/a | |
| $20.6M | n/a | n/a | |
| $20.0M | 255.4x | -8.6x | |
| $20.0M | n/a | n/a | |
| $19.8M | 2.8x | 7.8x | |
| $19.4M | n/a | n/a | |
| $18.2M | n/a | -3.9x | |
| $17.5M | n/a | n/a | |
| $15.2M | n/a | n/a | |
| $15.1M | n/a | n/a | |
| $15.0M | n/a | n/a | |
| $14.8M | n/a | n/a | |
| $14.6M | n/a | n/a | |
| $14.5M | 2.5x | -5.3x | |
| $13.9M | n/a | n/a | |
| $13.6M | 9.8x | -3.5x | |
| $13.4M | n/a | n/a | |
| $13.2M | n/a | n/a | |
| $12.7M | 0.8x | -7.4x | |
| $12.0M | 8.3x | -0.7x | |
| $11.8M | n/a | n/a | |
| $11.8M | n/a | n/a | |
| $10.9M | 1.7x | -0.2x | |
| $10.8M | n/a | n/a | |
| $9.9M | 6.5x | -28.8x | |
| $9.9M | n/a | n/a | |
| $9.9M | 5.5x | -0.7x | |
| $9.8M | n/a | n/a | |
| $9.7M | n/a | n/a | |
| $9.6M | 9.3x | -37.8x | |
| $9.6M | n/a | n/a | |
| $9.1M | n/a | n/a | |
| $8.9M | n/a | -2.2x | |
| $8.7M | n/a | n/a | |
| $8.7M | n/a | n/a | |
| $8.6M | n/a | n/a | |
| $8.5M | 1.3x | -0.9x | |
| $8.2M | n/a | -1.6x | |
| $8.0M | n/a | n/a | |
| $7.8M | n/a | n/a | |
| $7.2M | n/a | n/a | |
| $6.9M | n/a | -2.2x | |
| $6.7M | n/a | n/a | |
| $6.4M | n/a | -1.8x | |
| $5.8M | n/a | n/a | |
| $5.6M | 49.7x | -1.8x | |
| $5.5M | n/a | n/a | |
| $5.2M | n/a | n/a | |
| $4.9M | 7.3x | -4.0x | |
| $4.7M | 1.3x | -1.8x | |
| $4.4M | n/a | n/a | |
| $3.7M | n/a | n/a | |
| $3.4M | n/a | n/a | |
| $2.9M | n/a | n/a | |
| $2.8M | n/a | n/a | |
| $2.5M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $2.2M | 1.6x | -0.3x | |
| $2.1M | n/a | n/a | |
| $1.9M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.5M | n/a | n/a | |
| $1.3M | n/a | n/a | |
| $1.2M | n/a | -1.5x | |
| $1.0M | n/a | n/a | |
| $0.8M | n/a | -1.6x | |
| $0.7M | n/a | n/a | |
| -$0.2M | n/a | n/a | |
| -$0.6M | n/a | n/a | |
| -$0.9M | n/a | n/a | |
| -$1.0M | n/a | n/a | |
| -$1.1M | -0.7x | n/a | |
| -$1.1M | n/a | 0.3x | |
| -$4.2M | n/a | n/a | |
| -$6.8M | n/a | n/a | |
| -$19.2M | n/a | n/a | |
| -$37.1M | n/a | n/a | |
| -$48.6M | -2.9x | 0.3x | |
| -$113M | n/a | 0.7x | |
| -$1.4B | -4.4x | 4.5x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals